131 related articles for article (PubMed ID: 23528439)
21. Pathogenic role of monocytes/macrophages in large vessel vasculitis.
Watanabe R; Hashimoto M
Front Immunol; 2022; 13():859502. PubMed ID: 35967455
[TBL] [Abstract][Full Text] [Related]
22. Cellular Signaling Pathways in Medium and Large Vessel Vasculitis.
Watanabe R; Berry GJ; Liang DH; Goronzy JJ; Weyand CM
Front Immunol; 2020; 11():587089. PubMed ID: 33072134
[TBL] [Abstract][Full Text] [Related]
23. Giant cell arteritis. Epidemiology, etiology and pathogenesis.
Nordborg C; Nordborg E; Petursdottir V
APMIS; 2000 Nov; 108(11):713-24. PubMed ID: 11211963
[TBL] [Abstract][Full Text] [Related]
24. Metalloproteinase-2 and -9 in giant cell arteritis: involvement in vascular remodeling.
Rodríguez-Pla A; Bosch-Gil JA; Rosselló-Urgell J; Huguet-Redecilla P; Stone JH; Vilardell-Tarres M
Circulation; 2005 Jul; 112(2):264-9. PubMed ID: 15998676
[TBL] [Abstract][Full Text] [Related]
25. Tissue-destructive macrophages in giant cell arteritis.
Rittner HL; Kaiser M; Brack A; Szweda LI; Goronzy JJ; Weyand CM
Circ Res; 1999 May; 84(9):1050-8. PubMed ID: 10325242
[TBL] [Abstract][Full Text] [Related]
26. Cytokines in giant-cell arteritis.
Goronzy JJ; Weyand CM
Cleve Clin J Med; 2002; 69 Suppl 2():SII91-4. PubMed ID: 12086274
[TBL] [Abstract][Full Text] [Related]
27. Vascular dendritic cells in giant cell arteritis.
Weyand CM; Ma-Krupa W; Pryshchep O; Gröschel S; Bernardino R; Goronzy JJ
Ann N Y Acad Sci; 2005 Dec; 1062():195-208. PubMed ID: 16461802
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-1 blockade in refractory giant cell arteritis.
Ly KH; Stirnemann J; Liozon E; Michel M; Fain O; Fauchais AL
Joint Bone Spine; 2014 Jan; 81(1):76-8. PubMed ID: 23890680
[TBL] [Abstract][Full Text] [Related]
29. Platelet-derived growth factor, intimal hyperplasia, and ischemic complications in giant cell arteritis.
Kaiser M; Weyand CM; Björnsson J; Goronzy JJ
Arthritis Rheum; 1998 Apr; 41(4):623-33. PubMed ID: 9550471
[TBL] [Abstract][Full Text] [Related]
30. Pathogenic principles in giant cell arteritis.
Weyand CM; Goronzy JJ
Int J Cardiol; 2000 Aug; 75 Suppl 1():S9-S15; discussion S17-9. PubMed ID: 10980331
[TBL] [Abstract][Full Text] [Related]
31. Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism.
Hernández-Rodríguez J; Segarra M; Vilardell C; Sánchez M; García-Martínez A; Esteban MJ; Grau JM; Urbano-Márquez A; Colomer D; Kleinman HK; Cid MC
Circulation; 2003 May; 107(19):2428-34. PubMed ID: 12742994
[TBL] [Abstract][Full Text] [Related]
32. Pro-inflammatory and anti-inflammatory T cells in giant cell arteritis.
Watanabe R; Hosgur E; Zhang H; Wen Z; Berry G; Goronzy JJ; Weyand CM
Joint Bone Spine; 2017 Jul; 84(4):421-426. PubMed ID: 27663755
[TBL] [Abstract][Full Text] [Related]
33. New insights into the pathogenesis of giant cell arteritis and hopes for the clinic.
Carmona FD; Martín J; González-Gay MA
Expert Rev Clin Immunol; 2016; 12(1):57-66. PubMed ID: 26367100
[TBL] [Abstract][Full Text] [Related]
34. Giant cell arteritis--a molecular approach to the multiple facets of the syndrome.
Weyand CM; Hafner V; Kaiser M; Goronzy JJ
Ann Med Interne (Paris); 1998 Nov; 149(7):420-4. PubMed ID: 9921395
[TBL] [Abstract][Full Text] [Related]
35. Giant cell arteritis: immune and vascular aging as disease risk factors.
Mohan SV; Liao YJ; Kim JW; Goronzy JJ; Weyand CM
Arthritis Res Ther; 2011 Aug; 13(4):231. PubMed ID: 21861860
[TBL] [Abstract][Full Text] [Related]
36. Genetic component of giant cell arteritis.
Carmona FD; González-Gay MA; Martín J
Rheumatology (Oxford); 2014 Jan; 53(1):6-18. PubMed ID: 23843109
[TBL] [Abstract][Full Text] [Related]
37. Immunology of Giant Cell Arteritis.
Weyand CM; Goronzy JJ
Circ Res; 2023 Jan; 132(2):238-250. PubMed ID: 36656970
[TBL] [Abstract][Full Text] [Related]
38. The pathogenesis of giant cell arteritis: morphological aspects.
Nordborg C; Nordborg E; Petursdottir V
Clin Exp Rheumatol; 2000; 18(4 Suppl 20):S18-21. PubMed ID: 10948752
[TBL] [Abstract][Full Text] [Related]
39. Increased angiotensin II type 1 receptor expression in temporal arteries from patients with giant cell arteritis.
Dimitrijevic I; Malmsjö M; Andersson C; Rissler P; Edvinsson L
Ophthalmology; 2009 May; 116(5):990-6. PubMed ID: 19410957
[TBL] [Abstract][Full Text] [Related]
40. [Clinical, laboratory, radiological features, and outcome in 26 patients with aortic involvement amongst a case series of 63 patients with giant cell arteritis].
Daumas A; Rossi P; Bernard-Guervilly F; Francès Y; Berbis J; Durand JM; Kaplanski G; Ebbo M; Harlé JR; Weiller PJ; Serratrice J; Disdier P; Gayet S; Villani P; Granel B
Rev Med Interne; 2014 Jan; 35(1):4-15. PubMed ID: 23906779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
